Profitelligence Profitelligence · Filing Ledger Open CAH research →

Form 8-K · Current Report · Filed 2025-10-03

Cardinal Health extends receivables purchase agreement term

On September 30, 2025, Cardinal Health Funding, LLC, CH-23 Funding, LLC, and several financial institutions entered into a First Amendment to extend the term of the Fifth Amended and Restated Receivables Purchase Agreement to September 28, 2028.

Filer
Cardinal Health Inc. CAH · NYSE
Filed
Accession
0000721371-25-000122
CIK
0000721371
Signal
Medium impactHealthcare

Details

The Amendment, filed as Exhibit 10.1, details the changes made to the original agreement. Financial institutions involved have provided various services to the Company in the past and may continue to do so.

Items reported

Item 1.01

Entry into a Material Definitive Agreement

Financial Instrument Agreement
Item 9.01

Financial Statements and Exhibits

Exhibits Furnished

Market reaction

Close before filing

$158.46

Next session

-2.1%

Since filing

+45.2%

Latest close

$230.03

What happened, not what will happen — closing prices around the filing date.

Precedent

Previous filings from CAH reporting the same item, with the next session's move:

About Cardinal Health Inc.

Cardinal Health Inc. is a major global healthcare services and products company, distinguished for providing end-to-end medical solutions. Specializing in healthcare distribution and supply chain management, Cardinal Health serves a comprehensive array of clients including hospitals, pharmacies, and healthcare providers. Notably, the company distributes pharmaceuticals, medical products, and laboratory supplies, ensuring efficient delivery to improve healthcare outcomes. Based in Dublin, Ohio, Cardinal Health plays a pivotal role in enhancing healthcare operational efficiency, offering extensive services like inventory management, logistics optimization, and integrated healthcare solutions that empower providers to focus on patient care. As one of the largest pharmaceutical distributors in the United States, it holds substantial influence in the healthcare sector, pivotal in ensuring the availability of drugs and medical supplies across various platforms, contributing significantly to the healthcare infrastructure worldwide.

Exchange NYSE Industry Medical Distribution Company website ↗

Never miss another CAH filing

Profitelligence watches EDGAR around the clock and alerts you within seconds.

Set up free alerts